146 related articles for article (PubMed ID: 16941344)
21. A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process.
Teschner W; Butterweck HA; Auer W; Muchitsch EM; Weber A; Liu SL; Wah PS; Schwarz HP
Vox Sang; 2007 Jan; 92(1):42-55. PubMed ID: 17181590
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal changes in measles antibody titers in plasma donors and minimum antibody levels of immunoglobulin products for treatment of primary immunodeficiency.
Simon TL; FitzGerald P; Kühne M; Farrar C; Knowles J; Bycholski K; Zenker O
Transfusion; 2018 Dec; 58 Suppl 3():3065-3071. PubMed ID: 30536437
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin G from single plasma donor in immune globulin intravenous causes false positive pyrogen test.
Zervos C; Zimmerman TP; Willis T; Flexman G; Srivastava J; Silverstein R; Williams M; Vandeberg P; Culp JL; Burns D; Barham V; Durham A; Malinzak DA
Biologicals; 2019 May; 59():12-19. PubMed ID: 31023510
[TBL] [Abstract][Full Text] [Related]
24. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
[TBL] [Abstract][Full Text] [Related]
25. [Studies of IgG subclasses of anti-erythrocyte antibodies contained in human plasma preparation products].
Okubo S; Yasunaga K; Ishida T
Rinsho Ketsueki; 1989 Mar; 30(3):323-6. PubMed ID: 2769955
[TBL] [Abstract][Full Text] [Related]
26. Fc function of a new intravenous immunoglobulin product: IGIV 10% triple virally inactivated solution.
Reipert BM; Ilas J; Carnewal C; Füreder SF; Bölzlbauer U; Teschner W; Fiedler C; Schwarz HP
Vox Sang; 2006 Oct; 91(3):256-63. PubMed ID: 16958839
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of neutralizing antibody titers against human cytomegalovirus in intravenous gamma globulin preparations.
Roy DM; Grundy JE
Transplantation; 1992 Dec; 54(6):1109-10. PubMed ID: 1334581
[No Abstract] [Full Text] [Related]
28. Measles susceptibility in a university student population.
Eberhart-Phillips J; Dickson N; Jerram J; Jenkins R; Zwehl-Burke S
N Z Med J; 1997 Jul; 110(1048):278-9. PubMed ID: 9269293
[No Abstract] [Full Text] [Related]
29. Oral fluid, a substitute for serum to monitor measles IgG antibody?
Goyal A; Shaikh NJ; Kinikar AA; Wairagkar NS
Indian J Med Microbiol; 2009; 27(4):351-3. PubMed ID: 19736406
[TBL] [Abstract][Full Text] [Related]
30. [Regulation of autoreactivity by the idiotypic network and therapeutic modulation of autoimmunity by polyvalent intravenous immunoglobulins (IgIV)].
Lacroix-Desmazes S; Kaveri S; Kazatchkine MD
Rev Neurol (Paris); 1996 May; 152(5):349-54. PubMed ID: 8881428
[TBL] [Abstract][Full Text] [Related]
31. Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months.
Techasena W; Sriprasert P; Pattamadilok S; Wongwacharapipoon P
J Med Assoc Thai; 2007 Jan; 90(1):106-12. PubMed ID: 17621740
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA.
Jansen van Vuren P; Potgieter AC; Paweska JT; van Dijk AA
J Virol Methods; 2007 Mar; 140(1-2):106-14. PubMed ID: 17174410
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors.
Huiss S; Damien B; Schneider F; Muller CP
Clin Exp Immunol; 1997 Sep; 109(3):416-20. PubMed ID: 9328115
[TBL] [Abstract][Full Text] [Related]
34. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
Egami T; Egami K; Tanoue A
Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
[TBL] [Abstract][Full Text] [Related]
35. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
36. Presence of high-titer neutralizing antibodies against enterovirus 71 in intravenous immunoglobulin manufactured from Chinese donors.
Cao R; Han J; Deng Y; Yu M; Qin E; Qin C
Clin Infect Dis; 2010 Jan; 50(1):125-6. PubMed ID: 20001529
[No Abstract] [Full Text] [Related]
37. Plasma Donors in the Southwestern United States Positively Contribute to the Diverse Therapeutic Antibody Profile of Immune Globulin Products.
Ciencewicki JM; Schouest KR; Gierman TM; Vandeberg PJ; Gooch BD
Sci Rep; 2020 Apr; 10(1):6850. PubMed ID: 32321978
[TBL] [Abstract][Full Text] [Related]
38. Long-term monitoring of virus antibody titers in human intravenous immunoglobulin lots derived from donors in Japan.
Onodera H; Nakagawa R; Nakagawa H; Urayama T; Haino K; Yunoki M
Transfusion; 2018 Nov; 58(11):2617-2626. PubMed ID: 30284288
[TBL] [Abstract][Full Text] [Related]
39. Distribution of serum measles-neutralizing antibodies according to age in women of childbearing age in France in 2005-2006: impact of routine immunization.
Pinquier D; Gagneur A; Aubert M; Brissaud O; Le Guen CG; Hau-Rainsard I; Picherot G; De Pontual L; Stephan JL; Reinert P
Pediatr Infect Dis J; 2007 Aug; 26(8):749-50. PubMed ID: 17848891
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the cause of increased measles incidence in Xinjiang, China in 2004.
Yu X; Wang S; Guan J; Mahemuti ; Purhati ; Gou A; Liu Q; Jin X; Ghildyal R
Pediatr Infect Dis J; 2007 Jun; 26(6):513-8. PubMed ID: 17529869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
